Sage Therapeutics Inc (SAGE)
12.89
-0.44
(-3.30%)
USD |
NASDAQ |
Apr 22, 16:00
12.90
+0.01
(+0.08%)
After-Hours: 20:00
Sage Therapeutics Cash from Operations (TTM): -540.58M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -540.58M |
September 30, 2023 | -548.00M |
June 30, 2023 | -531.00M |
March 31, 2023 | -505.92M |
December 31, 2022 | -460.04M |
September 30, 2022 | -430.60M |
June 30, 2022 | -380.57M |
March 31, 2022 | -376.90M |
December 31, 2021 | -378.18M |
September 30, 2021 | 730.29M |
June 30, 2021 | 708.10M |
March 31, 2021 | 691.88M |
December 31, 2020 | 664.28M |
September 30, 2020 | -463.42M |
June 30, 2020 | -501.10M |
March 31, 2020 | -515.46M |
December 31, 2019 | -528.71M |
September 30, 2019 | -513.76M |
June 30, 2019 | -465.24M |
March 31, 2019 | -332.03M |
December 31, 2018 | -260.67M |
Date | Value |
---|---|
September 30, 2018 | -217.79M |
June 30, 2018 | -183.70M |
March 31, 2018 | -242.64M |
December 31, 2017 | -219.28M |
September 30, 2017 | -194.15M |
June 30, 2017 | -178.86M |
March 31, 2017 | -146.45M |
December 31, 2016 | -118.68M |
September 30, 2016 | -103.02M |
June 30, 2016 | -91.74M |
March 31, 2016 | -83.51M |
December 31, 2015 | -70.68M |
September 30, 2015 | -61.23M |
June 30, 2015 | -49.20M |
March 31, 2015 | -36.03M |
December 31, 2014 | -27.04M |
September 30, 2014 | -23.41M |
June 30, 2014 | -21.10M |
March 31, 2014 | -20.09M |
December 31, 2013 | -17.52M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-548.00M
Minimum
Sep 2023
730.29M
Maximum
Sep 2021
-228.68M
Average
-463.42M
Median
Sep 2020
Cash from Operations (TTM) Benchmarks
Biogen Inc | 1.547B |
Perspective Therapeutics Inc | -36.91M |
Vanda Pharmaceuticals Inc | 12.80M |
ADMA Biologics Inc | 8.80M |
Finch Therapeutics Group Inc | -31.50M |